戻る Agenda
Session 8 Track 1: Hot Topics
Session Chair(s)
Amy Van Sant, PharmD, MBA
President, Medical Affairs
Inizio Engage, United States
Our environment is constantly changing, and companies face increasing challenges to deliver high-quality and impactful medical communications. This session will touch on three ‘hot topics’ trending in the industry that may shape how we work in the future. Guest speakers will review some of the cutting edge work they are doing around these hot topics. The format of this session will be informal and audience questions are encouraged.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss the complexities, challenges and successes in medical communications in light of FDA Guidance impacting medical communications
- Examine on a global level the impact of health equity
- Describe the impact of medical communications under an Emergency Use Authorizations (EUA)
- Identify emerging trends and their impact on Medical Communications
Speaker(s)
FDA Guidance
Hira Shah, PharmD
Regeneron, United States
Director, Regulatory Affairs Advertising & Promotion
Health Equity
Stephanie Young Moss, PharmD, MS
Integrative Pharmacy Outcomes and Consulting, United States
Pharmacist, Owner
Virtual Congresses
Constance Stangarone
Genentech, United States
Convention Services, Principal Manager